Answer
The Ranbaxy (UK) Limited a Sun Pharmaceutical Company oxaliplatin 5 mg/ml concentrate for solution for infusion product should not be mixed with other medicinal products except those mentioned in section 6.6 of its SmPC.
Sources for this answer
- Oxaliplatin 5 mg/ml concentrate for solution for infusionRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §6.2 Incompatibilities · Version 11Document updated
Sources checked